UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

The Lancet (British edition), 2016-12, Vol.388 (10062), p.2873-2884

2016

Volltextzugriff (PDF)

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Journal of Alzheimer's disease, 2018-01, Vol.61 (1), p.435

2018

Volltextzugriff (PDF)

IMAGING IN ALZHEIMER'S DISEASE TRIALS: IMPACT ON PATIENT RECRUITMENT, RETENTION AND LOGISTICS

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P509-P509

Shamsi, Kohkan

2016

Volltextzugriff (PDF)

P1‐257: Imaging in Alzheimer's Disease Trials: Impact on Patient Recruitment, Retention and Logistics

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_10), p.P509-P509

Shamsi, Kohkan

2016

Volltextzugriff (PDF)

MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325

Radiology, 2005-09, Vol.236 (3), p.825

2005

Volltextzugriff (PDF)

Don't Throw Away RECIST 1.1 Quite Yet

Radiology, 2019-04, Vol.291 (1), p.268

2019

Volltextzugriff (PDF)

A Summary of Safety of Gadofosveset (MS-325) at 0.03 mmol/kg Body Weight Dose: Phase II and Phase III Clinical Trials Data

Investigative radiology, 2006-11, Vol.41 (11), p.822-830

2006

Volltextzugriff (PDF)

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

Radiology, 2005-10, Vol.237 (1), p.89

2005

Volltextzugriff (PDF)

Onsite image evaluations and independent image blinded reads: close cousins or distant relatives?

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2103-2104

2009

Volltextzugriff (PDF)

Vasovist-enhanced MR angiography

European radiology, 2006-02, Vol.16 Suppl 2 (S2), p.B9-B14

2006

Volltextzugriff (PDF)

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial

Journal of computer assisted tomography, 2010-03, Vol.34 (2), p.163-172

2010

Volltextzugriff (PDF)

On and offsite image reads: is basing drug efficacy on the site read risky business?

Applied clinical trials, 2010-01, Vol.19 (1), p.S6

2010

Volltextzugriff (PDF)

On and Offsite Image Reads

Applied clinical trials, 2010-01, Vol.19 (1), p.S6

2010

Volltextzugriff (PDF)

Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US

European radiology, 2003-02, Vol.13 (2), p.262-272

2003

Volltextzugriff (PDF)

Coronary arteries: contrast-enhanced MR imaging with SH L 643A--experience in 12 volunteers

Radiology, 2003-10, Vol.229 (1), p.217

2003

Volltextzugriff (PDF)

MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial

Radiology, 2003-12, Vol.229 (3), p.811

2003

Volltextzugriff (PDF)

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

Radiology, 1996-04, Vol.199 (1), p.177

1996

Volltextzugriff (PDF)

MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease

Radiology, 2004-11, Vol.233 (2), p.567

2004

Volltextzugriff (PDF)

A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease

European journal of radiology, 2008-02, Vol.65 (2), p.316-325

2008

Volltextzugriff (PDF)

Conspicuity of liver hemangiomas: Short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid

Journal of magnetic resonance imaging, 2005-04, Vol.21 (4), p.391-397

2005

Volltextzugriff (PDF)

Eovist Injection and Resovist Injection: two new liver-specific contrast agents for MRI

Oncology (Williston Park, N.Y.), 2000-06, Vol.14 (6 Suppl 3), p.37-40

2000

Volltextzugriff (PDF)

Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging

Radiology, 1998-02, Vol.206 (2), p.365

1998

Volltextzugriff (PDF)

Focal nodular hyperplasia of the liver : radiologic findings

Abdominal imaging, 1993-01, Vol.18 (1), p.32-38

1993

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Male
(20)
Female
(19)
Contrast Media
(17)
Middle Aged
(17)
Aged
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adult
(10)
Gadolinium
(10)
Liver Neoplasms - Diagnosis
(9)
Sensitivity And Specificity
(9)
Aged, 80 And Over
(8)
Investigative Techniques, Diagnostic Techniques
(8)
Gadolinium Dtpa
(7)
Radiodiagnosis. Nmr Imagery. Nmr Spectrometry
(7)
Dose-Response Relationship, Drug
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

IMAGING IN ALZHEIMER'S DISEASE TRIALS: IMPACT ON PATIENT RECRUITMENT, RETENTION AND LOGISTICS

P1‐257: Imaging in Alzheimer's Disease Trials: Impact on Patient Recruitment, Retention and Logistics

MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325

Don't Throw Away RECIST 1.1 Quite Yet

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

A Summary of Safety of Gadofosveset (MS-325) at 0.03 mmol/kg Body Weight Dose: Phase II and Phase III Clinical Trials Data

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

Onsite image evaluations and independent image blinded reads: close cousins or distant relatives?

Vasovist-enhanced MR angiography

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial

On and offsite image reads: is basing drug efficacy on the site read risky business?

On and Offsite Image Reads

Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US

Coronary arteries: contrast-enhanced MR imaging with SH L 643A--experience in 12 volunteers

Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study

MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease

A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease

Conspicuity of liver hemangiomas: Short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid

Eovist Injection and Resovist Injection: two new liver-specific contrast agents for MRI

Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging

Focal nodular hyperplasia of the liver : radiologic findings

Suchergebnisse filtern